Skip to the page

Data / Form D filings / Avana Health, Inc.

Avana Health, Inc.: Form D filings

Avana Health, Inc., a pharmaceuticals company in Lexington, KY, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on December 19, 2025, reports $2.8 million sold of a $4 million offering to 29 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1537 BULL LEE ROAD, SUITE 200, Lexington, KY, 40511
Phone
(260) 668-0322
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1952808

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 19, 2025New notice$4,000,000$2,774,997$1,225,00329Sep 30, 2025sec.gov
Aug 7, 2023New notice$900,000$120,000$780,0001Jul 31, 2023sec.gov
Nov 15, 2022New notice$510,000$127,500$382,5002Oct 31, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter PacultExecutive Officer, Director
Howard SettleExecutive Officer, Director
John MoreheadExecutive Officer, Director

Every Form D from the week of Dec 15, 2025 · All recent filings in Kentucky · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Avana Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.